Concepedia

Robert J. Strohschein

RJ

Statistics

Publications

8

Citations

401

H-Index

8

Active since

1974

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Tris Pharma (United States)

Robert J. Strohschein is an author at Novartis (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1974–2001

8

Publications

8

The Effect of 1,3-Diaryl-[1H]-pyrazole-4-acetamides on Glucose Utilization in ob/ob Mice

Gregory R. Bebernitz, Greg Argentieri, Beverly Battle et al. · Journal of Medicinal Chemistry · 2001 · 141 citations

, , +17

Extracellular Glutamate and Other Metabolites in and Around RG2 Rat Glioma: An Intracerebral Microdialysis Study

P. F. Behrens, H. Langemann, Robert J. Strohschein et al. · Journal of Neuro-Oncology · 2000 · 96 citations

, , +14

Anilides of (<i>R</i>)-Trifluoro-2-hydroxy-2-methylpropionic Acid as Inhibitors of Pyruvate Dehydrogenase Kinase

Gregory R. Bebernitz, Thomas D. Aicher, James L. Stanton et al. · Journal of Medicinal Chemistry · 2000 · 60 citations · Full text

, , +16

(<i>R</i>)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides Are Orally Active Inhibitors of Pyruvate Dehydrogenase Kinase

Thomas D. Aicher, Robert C. Anderson, Gregory R. Bebernitz et al. · Journal of Medicinal Chemistry · 1999 · 44 citations · Full text

, , +8

Reversals in regiospecificity. The reactivity of vinylogous amides toward bis-electrophiles

G. B. BENNETT, WRJ Simpson, Robert B. Mason et al. · The Journal of Organic Chemistry · 1977 · 25 citations

, , +8

1–5 of 8